Clinical Research

Thumbnail

For the first time, researchers find a way to spot early signs of pancreatic cancer on routine MRI

Pancreatic cancer is one of the deadliest cancers, with a five-year survival rate of only 44% if caught early, dropping down to 3% if it metastasizes. This is largely due to its ability to elude detection.

Thumbnail

How opioid use disorder affects brain size and function

The CDC estimates that over 6 million people in the U.S. struggle with OUD, and prior research has indicated that only 20% receive treatment for the disorder.

Non-enhancing asymmetries on contrast-enhanced mammography

Is additional imaging necessary for non-enhancing asymmetries on contrast-enhanced mammograms?

Patients with asymmetries on CEM typically are recalled for additional views, ultrasound and occasionally MRI. But the extra workup might not be necessary.

maya kowalski case

Non-invasive imaging technique may be key to diagnosing sepsis earlier

The methods enable providers to identify signs of sepsis by assessing blood flow throughout the muscles. 

Thumbnail

Concussions may slow 'background' brain activity in athletes, new imaging shows

New research into post-concussion brain health suggests that the impact of head trauma may be more far-reaching than previously believed. 

Thumbnail

Vaping may affect vascular function as much or more than smoking, MRI study shows

E-cigarettes, or vapes, are largely considered a safer alternative to smoking tobacco cigarettes, but new MRI data suggest they still pose significant risk to users’ health. 

Cardiothoracic surgeons at Emory University Hospital have implanted the BrioVAD System, a new type of ventricular assist device (VAD) from BrioHealth Solutions, for the very first time in the United States.

Surgeons make history with first US implant of new magnetically suspended heart pump

Cardiothoracic surgeons at Emory University Hospital implanted the BrioVAD System, a new type of ventricular assist device from BrioHealth Solutions, for the very first time in the United States. The advanced technology, designed to minimize adverse events and improve quality of life, has been under development since 2008. 

Daniel Judge, MD, director of the cardiovascular genetics program, Medical University of South Carolina, the Edwin W. and Teresa H. Rogers Endowed Chair for Cardiovascular Research, Medical University of South Carolina, presented the results of the late-breaking ATTRibute-CM study for the drug acoramidis used to treat transthyretin amyloidosis at AHA 2024.

ATTR-CM drug acoramidis, now approved by the FDA, linked to positive long-term data

Cardiovascular Business spoke with cardiologist Daniel Judge, MD, about the long-term benefits of acoramidis, a new drug therapy that just received FDA approval to treat transthyretin amyloid cardiomyopathy.